Live Breaking News & Updates on Repare Therapeutics
Stay updated with breaking news from Repare therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Repare Therapeutics Announces Fast Track Designation Granted by the FDA for Lunresertib in Combination with Camonsertib for the Treatment of Platinum-Resistant Ovarian Cancer financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.
Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, today announced that members of its senior management team will participate in a fireside chat at the Goldman Sachs. ....
Repare Therapeutics to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference financialpost.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialpost.com Daily Mail and Mail on Sunday newspapers.
Repare Therapeutics (NASDAQ:RPTX – Get Free Report)‘s stock had its “buy” rating restated by stock analysts at HC Wainwright in a research report issued on Thursday, Benzinga reports. They presently have a $10.00 target price on the stock. HC Wainwright’s price target would indicate a potential upside of 187.36% from the stock’s previous close. Separately, […] ....
Repare Therapeutics Inc. , a leading clinical-stage precision oncology company, announced initial data from the Phase 1 MINOTAUR study evaluating lunresertib in combination with FOLFIRI for the. ....